Debt

Takeda to vote on $62bn Shire acquisition, looming debt a factor

13-Nov-2018 By Maggie Lynch

Takeda Pharmaceutical will hold an investor vote next month on the $62bn acquisition of rare disease specialist, Shire.

Unilife undecided on takeover plans; gives December 31 deadline

10-Nov-2015 By Fiona BARRY

Unilife CEO Alan Shortall yesterday confirmed the drug delivery company is still “receiving interest from several parties under the strategic review process” and set a deadline of December 31 to announce any potential takeover.  The company received its...

Charles River’s Q2 Buoyed by RMS Division, Recent Acquisitions

06-Aug-2013

CRO Charles River Laboratories saw slight growth in Q2 thanks to its Research Models & Services (RMS) division and two recent acquisitions.

Late-stage work will boost PPD's revs, but costs will hit margins says S&P

15-Oct-2012 By Gareth Macdonald

Returning demand for late-phase trial services will help PPD grow revenue in 2013 but rising labour costs will impact earnings says S&P.

Cetero warns of “fatal” funding alternatives in defence of sale

23-Apr-2012 By Nick Taylor

Cetero has hit back at critics of its financing plan by saying use of third-party funders would cause a “likely fatal” fight.

Cetero sale time extended after creditors call it “objectionable”

16-Apr-2012 By Nick TAYLOR

The Delaware Bankruptcy Court has extended the Cetero sale period by 11 days after some creditors called the timeline “objectionable”.

Big clients to drive high single-digit growth at Quintiles; S&P

23-Feb-2012 By Nick Taylor

S&P is predicting up to high single-digit near-term growth at Quintiles but rising costs and early phase capacity issues will pressure profits.

update

Quintiles resurrects refinancing plan

11-May-2011 By Gareth Macdonald

US contract research organisation (CRO) Quintiles has resurrected plans to refinance in a bid to clear debts in a more healthy credit market.

update

Quintiles halts financing plan after market becomes ‘unfavourable’

23-Mar-2011 By Gareth Macdonald

US CRO Quintiles has postponed a financing plan it announced earlier this month, citing unfavourable global credit market conditions as the reason for the decision.

PharmEng to make proposal under bankruptcy act

15-Apr-2009

PharmEng has filed a notice of intent (NOI) to make a proposal under the Canadian Bankruptcy and Insolvency Act in an attempt to “regain the company's financial footing”.

LyondellBasell struggling with debt and global slump

06-Jan-2009 By Gareth Macdonald

LyondellBasell, the world’s third largest petrochemicals firm and a major supplier to the drug industry, is close to bankruptcy according to widespread media reports as it struggles under the weight of a $26bn (€19.4) debt and a slump in demand for its...

Syscan files for bankruptcy

16-Dec-2008 By Nick Taylor

The global financial difficulties are starting to hit home in the outsourcing sector, with supply chain services company Syscan filing for bankruptcy after being unable to secure a loan.

Outsourcing-Pharma.com special focus

Charting the course of Inyx' downfall

10-Jul-2007 By Kirsty Barnes

With a knife-edge financial history of spiralling debts,
exacerbated by continued borrowing, Inyx' recent insolvency
problems are hardly surprising.

Solutia bankruptcy exit route meets roadblock

15-Jun-2005

Solutia has drawn up an agreement with former parent Monsanto that
could finally bring it out of the state of bankruptcy
reorganisation it has resided in since the end of 2003, reports
Phil Taylor.